ReviewThe Lancet regional health. Southeast Asia2025
Addressing influenza in Bangladesh: closing evidence and policy gaps with strategic interventions.
Review in The Lancet regional health. Southeast Asia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Seasonality and clinical characteristics of influenza-like illness and severe acute respiratory infection in children under 5 years in Cox's Bazar, Bangladesh (2021-2023).IJID regions · 2026Article
- A strategic blueprint for strengthening respiratory syncytial virus prevention among under-five children in low- and middle-income countries: Bangladesh as a model for new immunisation approaches.Journal of global health · 2026Article
- Human Metapneumovirus: A Neglected Contributor to Acute Respiratory Infections in Bangladesh: A Public Health Perspective.Health science reports · 2026Article
- Improving Influenza Vaccine Uptake in Low- and Lower-Middle-Income Countries: A Synthesis of Interventions and Strategic Recommendations.Open forum infectious diseases · 2026Review
- Incidence and Viral Etiology of Acute Respiratory Infections and Pneumonia among Children Under Two Years: A Birth Cohort Study in Dhaka, Bangladesh.The American journal of tropical medicine and hygiene · 2026Article
- Innovative hematological strategies to combat maternal and child mortality in Africa: focus on anemia and sickle cell disease.Annals of medicine and surgery (2012) · 2026Review
- Article
- Sustaining Local Production of Influenza Vaccines: A Global Study of Enabling Factors Among Vaccine Manufacturers.Vaccines · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since the establishment of the National Influenza Surveillance Program in 2007, Bangladesh has significantly progressed in monitoring influenza through national and international collaboration. However, this collaboration has not been translated into actionable control policies, which coupled with low vaccination coverage, impose a substantial health and economic burden in Bangladesh. Critical gaps remain in understanding the influenza burden among high-risk populations and the barriers influencing their vaccine uptake. These gaps hinder the development of evidence-based strategies for prevention and control, consequently leaving the country vulnerable to a potentially catastrophic influenza epidemic. These challenges require a multifaceted approach, including continuous local data collection on disease burden and vaccine barriers, vaccine cost-effectiveness analyses, and the design of context-specific interventions. Leveraging existing infrastructures offers opportunities to develop tailored strategies for high-risk populations. A robust national influenza policy is imperative to mitigate the burden and reduce future pandemic threats.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.